We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3750:HKEXContemporary Amperex Technology Co., Limited Class H Analysis

Data as of 2026-09-04 - not real-time

HK$574.50

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Contemporary Amperex Technology Co., Limited is neutral at HKD 574.50, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 7.6%. Relative strength is 35.2 — approaching oversold — and the MACD signal is bearish. Price has been bracketed by support at HKD 563.50 and resistance at HKD 667.00.
The shares look fair, trading on 26.3 times earnings in line with a sector average of 28.4. Consensus targets land 38.9% above where the shares trade now. Revenue is growing at 56.9% on a 16.3% profit margin.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 38.1%, a beta of 0.49 and a maximum drawdown of 27.6%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.

Top Market Events

Seeking Alpha3monContemporary Amperex Technology: Still A Bull On Encouraging DevelopmentsI've stayed positive on...Barron's1dContemporary Amperex Technology Co.Detailed price information for Contemporary Amperex Tech CTATF from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 594.39
  • MACD momentum is negative
  • 30-day price change of -7.6%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 26.3 versus sector average of 28.4
  • Trading below the 200-day average of 594.39
  • Analyst targets imply +38.9% versus the current price

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 26.3 versus sector average of 28.4
  • Analyst targets imply +38.9% versus the current price
  • Profit margin of 16.3% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth56.90%
Profit Margin16.29%
P/E Ratio26.3
ROE24.77%
ROA5.83%
Debt/Equity35.99
P/B Ratio6.0
Op. Cash FlowHK$134.7B
Free Cash FlowHK$73.9B
Industry P/E28.4

Technical Analysis

TrendNeutral
RSI35.2
SupportHK$563.50
ResistanceHK$667.00
MA 20HK$622.93
MA 50HK$630.50
MA 200HK$594.39
MACDBearish
VolumeIncreasing
Fear & Greed Index96.13

Valuation

Fair ValueHK$612.19
Target PriceHK$797.89
Upside/Downside38.89%
GradeFair
TypeGrowth

Risk Assessment

Beta0.49
Volatility38.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.